Literature DB >> 31531389

Fibroblast Gap-closure Assay-Microscopy-based in vitro Assay Measuring the Migration of Murine Fibroblasts.

Agnieszka P Looney1, Mallar Bhattacharya1.   

Abstract

Pulmonary fibrosis is characterized by pathological scaring of the lung. Similar to other fibrotic diseases, scar formation is driven by excessive extracellular matrix deposition by activated, proliferative, and migratory fibroblasts. Currently, the two most widely used chemotaxis and cell migration assays are the scratch assay and the transmembrane invasion assay. Here we present a gap closure assay that employs commercially available cell lines, equipment and reagents and is time efficient as well as straightforward. The protocol uses an Oris pro cell migration assay 96-well plate with a dissolvable plug in the center of each well to create a cell free area at the time of seeding. Cell repopulation of the empty zone is captured via light microscopy at different time points and quantified with free image analysis software. The clear advantages of this assay in comparison to similar protocols are the use of uncomplicated cell culture methods and the ability to image the experiment throughout.

Entities:  

Keywords:  Chemotaxis; Fibroblast; Fibrosis; Gap closure; Migration

Year:  2019        PMID: 31531389      PMCID: PMC6748635          DOI: 10.21769/BioProtoc.3333

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  7 in total

1.  Fibrosis--A Common Pathway to Organ Injury and Failure.

Authors:  Don C Rockey; P Darwin Bell; Joseph A Hill
Journal:  N Engl J Med       Date:  2015-07-02       Impact factor: 91.245

2.  In vitro cell migration and invasion assays.

Authors:  Calvin R Justus; Nancy Leffler; Maria Ruiz-Echevarria; Li V Yang
Journal:  J Vis Exp       Date:  2014-06-01       Impact factor: 1.355

3.  Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.

Authors:  Timothy S Blackwell; Andrew M Tager; Zea Borok; Bethany B Moore; David A Schwartz; Kevin J Anstrom; Ziv Bar-Joseph; Peter Bitterman; Michael R Blackburn; William Bradford; Kevin K Brown; Harold A Chapman; Harold R Collard; Gregory P Cosgrove; Robin Deterding; Ramona Doyle; Kevin R Flaherty; Christine Kim Garcia; James S Hagood; Craig A Henke; Erica Herzog; Cory M Hogaboam; Jeffrey C Horowitz; Talmadge E King; James E Loyd; William E Lawson; Clay B Marsh; Paul W Noble; Imre Noth; Dean Sheppard; Julie Olsson; Luis A Ortiz; Thomas G O'Riordan; Tim D Oury; Ganesh Raghu; Jesse Roman; Patricia J Sime; Thomas H Sisson; Daniel Tschumperlin; Shelia M Violette; Timothy E Weaver; Rebecca G Wells; Eric S White; Naftali Kaminski; Fernando J Martinez; Thomas A Wynn; Victor J Thannickal; Jerry P Eu
Journal:  Am J Respir Crit Care Med       Date:  2014-01-15       Impact factor: 21.405

Review 4.  Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment.

Authors:  Luke Bu; Hideo Baba; Naoya Yoshida; Keisuke Miyake; Tadahito Yasuda; Tomoyuki Uchihara; Patrick Tan; Takatsugu Ishimoto
Journal:  Oncogene       Date:  2019-02-28       Impact factor: 9.867

Review 5.  Fibroblasts in fibrosis: novel roles and mediators.

Authors:  Ryan T Kendall; Carol A Feghali-Bostwick
Journal:  Front Pharmacol       Date:  2014-05-27       Impact factor: 5.810

Review 6.  The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis.

Authors:  Omkar Desai; Julia Winkler; Maksym Minasyan; Erica L Herzog
Journal:  Front Med (Lausanne)       Date:  2018-03-20

7.  Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage.

Authors:  Dvir Aran; Agnieszka P Looney; Leqian Liu; Esther Wu; Valerie Fong; Austin Hsu; Suzanna Chak; Ram P Naikawadi; Paul J Wolters; Adam R Abate; Atul J Butte; Mallar Bhattacharya
Journal:  Nat Immunol       Date:  2019-01-14       Impact factor: 25.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.